Abbott Laboratories buy BTIG Research
Start price
16.10.25
/
50%
€110.96
Target price
16.10.26
€124.21
Performance (%)
-15.53%
Price
18:09
€93.73
Summary
This prediction is currently active. The price of Abbott Laboratories has decreased since the start of the prediction. Compared to the start price this results in a performance of -15.53%. This prediction currently runs until 16.10.26. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | -2.934% | -2.934% |
| iShares Core DAX® | -5,87 % | -2,50 % |
| iShares Nasdaq 100 | 1,66 % | 3,51 % |
| iShares Nikkei 225® | -6,13 % | 2,14 % |
| iShares S&P 500 | 0,50 % | 2,05 % |
Comments by BTIG_Research for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE:ABT) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $145.00 price target on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by BTIG_Research for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€95.00
18.02.26
18.02.26
€118.19
18.02.27
18.02.27
-1.34%
18:09
18:09
Abbott Laboratories
Start price
Target price
Perf. (%)
€107.90
20.11.25
20.11.25
€125.82
20.11.26
20.11.26
-13.13%
18:09
18:09
Abbott Laboratories
Start price
Target price
Perf. (%)
€104.68
18.07.25
18.07.25
€124.73
18.07.26
18.07.26
-10.46%
18:09
18:09